Epilepsy; CNS; pain; migraine; addiction; allergy; rheumatology; asthma;

Crossject develops and will commercialize through partners a portfolio of rescue treatments for emergency situations such as epileptic seizures, opioid overdoses, and severe asthma attacks.

Crossject’s breakthrough ZENEO® needle-free auto-injector enables the simple and intuitive intramuscular or subcutaneous self-administration of prefilled injectable drugs in less than a tenth of a second, in only two steps (open, push on injection site).